SEC Form 4 · accession 0001206386-18-000004
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard M Marsh
Officer — E.V.P., General Counsel
Period of report
Jan 18, 2018
Accepted (ET)
Jan 19, 2018 · 2:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2018 | M | 40,000 | $30.12 | A | 159,994 | D | |
| Common Stock | Jan 18, 2018 | S | 40,000 | $38.25 | D | 119,994 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $30.12 | Jan 18, 2018 | M | 40,000 | D | Jan 18, 2018 | Feb 18, 2019 | Common Stock | 40,000 | 37,654 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.